Exit
Before you view the activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit. There is no fee to participate in this activity.

Question Title

* 1. HCPs: What are your credentials?

Question Title

* 2. In what type of patients should molnupiravir be considered as a COVID-19 treatment?

Question Title

* 3. The disadvantage of using MOL versus PAX or RDV for COVID-19 infections in the outpatient setting is:

Question Title

* 4. 67-year-old male w/ Grade 4 CKD outpatient with COVID-19 symptom onset ≤5 days, tests positive for SARS-CoV-2 by PCR. Which antiviral do you recommend?

Question Title

* 5. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).

( Privacy & Cookie Notice

T